Dermatology Department of Hospital Universitario de la Princesa, Madrid, Spain.
Pathology Department of Hospital Universitario de la Princesa, Spain.
Actas Dermosifiliogr. 2023 Oct;114(9):747-754. doi: 10.1016/j.ad.2023.05.024. Epub 2023 Jun 16.
Despite the large number of articles published on skin lesions related to COVID-19, clinicopathological correlation has not been performed consistently and immunohistochemistry to demonstrate spike 3 protein expression has not been validated through RT-PCR.
We compiled 69 cases of patients with confirmed COVID-19, where skin lesions were clinically and histopathologically studied. Immunohistochemistry (IHC) and RT-PCR was performed in skin biopsies.
After a careful review of the cases, 15 were found to be dermatosis not related to COVID-19, while the rest of the lesions could be classified according to their clinical characteristics as vesicular (4), maculopapular eruptions (41), urticariform (9), livedo and necrosis (10) and pernio-like (5). Although histopathological features were similar to previously reported results, we found two previously unreported findings, maculopapular eruptions with squamous eccrine syringometaplasia and neutrophilic epitheliotropism. IHC showed in some cases endothelial and epidermal staining but RT-PCR was negative in all the tested cases. Thus, direct viral involvement could not be demonstrated.
Despite presenting the largest series of confirmed COVID-19 patients with histopathologically studied skin manifestations, direct viral involvement was difficult to establish. Vasculopathic and urticariform lesions seem to be those more clearly related to the viral infection, despite IHC or RT-PCR negative results failed to demonstrate viral presence. These findings, as in other dermatological areas, highlight the need of a clinico-pathological correlation to increase knowledge about viral involvement in COVID-19 skin-related lesions.
尽管有大量关于与 COVID-19 相关的皮肤损伤的文章发表,但临床病理相关性并未得到一致的研究,并且针对刺突 3 蛋白表达的免疫组化检测也未通过 RT-PCR 进行验证。
我们整理了 69 例确诊 COVID-19 患者的病例,对这些患者的皮肤损伤进行了临床和组织病理学研究。对皮肤活检进行了免疫组化(IHC)和 RT-PCR 检测。
在仔细审查这些病例后,我们发现有 15 例患者的皮肤病损与 COVID-19 无关,而其余的病变可根据其临床特征分为水疱(4 例)、斑丘疹(41 例)、荨麻疹样(9 例)、网状青斑和坏死(10 例)和冻疮样(5 例)。尽管组织病理学特征与之前报道的结果相似,但我们发现了两个之前未报道的发现,即斑丘疹伴有鳞状外泌汗腺化生和中性粒细胞上皮嗜性。免疫组化显示在一些病例中存在内皮和表皮染色,但所有检测病例的 RT-PCR 结果均为阴性。因此,无法直接证明病毒的参与。
尽管我们提供了最大的一组经组织病理学研究的确诊 COVID-19 患者的皮肤表现系列,但很难确定直接的病毒参与。血管病变和荨麻疹样病变似乎与病毒感染更为相关,尽管免疫组化或 RT-PCR 阴性结果未能证明病毒的存在。这些发现,与其他皮肤科领域一样,强调了需要进行临床病理相关性研究,以增加对 COVID-19 皮肤相关病变中病毒参与的认识。